Larvol Delta - Brentuximab-Vedotin-and-Nivolumab-for-the-Treatment-of-Patients-With-RelapsedRefractory-Classical-Hodgkin-Lymphoma

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Adcetris (brentuximab vedotin) - Takeda, Pfizer

http://clinicaltrials.gov/ct2/show/NCT04561206

Sep 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next